Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

Yung‐Jue Bang(Seoul National University), Young‐Woo Kim(National Cancer Center), Han‐Kwang Yang(Seoul National University), Hyun Cheol Chung(Yonsei University), Young Kyu Park(Chonnam National University), Kyung Hee Lee(Yeungnam University), Keun‐Wook Lee(Seoul National University Bundang Hospital), Yong Ho Kim(Kyung Hee University), Sang-Ik Noh(Veterans Health Service Medical Center), Y. Choi(Yonsei University), Young Jae Mok, Yeul Hong Kim(Korea University), Jiafu Ji(Peking University), Ta-Sen Yeh(Chang Gung University), Peter Button(Infosys (India)), Florin Sirzén(Roche (Switzerland)), Sung Hoon Noh(Yonsei University)
The Lancet
January 1, 2012
Cited by 1,720

Abstract


Related Papers

No related papers found

Powered by citation graph analysis